Searching map area
Bortezomib (PS-341) in relapsed or refractory extensive stage small cell lung cancer: a Southwest Oncology Group phase II trial (S0327).
? TBD
scientific article published in November 2006
2006
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Lists 0
Join to rate
Authors Primo N Lara, Kari Chansky, Angela M Davies, Wilbur A Franklin, Paul H Gumerlock, Perry P Guaglianone, James N Atkins, Nichole Farneth, Philip C Mack, John J Crowley, David R Gandara
Volume Vol. 1, No. 9, pp. 996-1001
Reading
DOI10.1016/S1556-0864(15)31633-6 PubMed
Instance of
Scholarly article
Author
David R Gandara
Subject
phase II clinical trial
References
Wikidata